晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2020版)

2020-12-15 中国临床肿瘤学会 中华医学杂志.2020.100(46):3659-3673.

本共识在《晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019年版)》的基础上,由共识专家组组长与执笔作者基于近1年来发表的临床研究证据,并结合临床经验,整理出共识初稿。之后由60名指南撰写专家组

中文标题:

晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2020版)

发布机构:

中国临床肿瘤学会

发布日期:

2020-12-15

简要介绍:

本共识在《晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019年版)》的基础上,由共识专家组组长与执笔作者基于近1年来发表的临床研究证据,并结合临床经验,整理出共识初稿。之后由60名指南撰写专家组成员经过专家组会议对共识更新内容进行讨论和修改,最终确定共识推荐内容。因此,本共识提出的推荐内容是基于现有的中国和国际高质量的循证医学证据以及专家组广泛认可的临床经验。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082411, encodeId=550c10824117e, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:13 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973643, encodeId=47ff9e3643a6, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/7569b126444c4b1b9ab8cbd298657008/59c094a3153443d698ed34d3414795a2.jpg, createdBy=eb1f5428506, createdName=医海无涯苦作舟, createdTime=Tue Jun 15 08:26:51 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952452, encodeId=0ea895245260, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f45460280, createdName=ms4000001483995114, createdTime=Tue Mar 30 19:14:41 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923790, encodeId=1a75923e9040, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/7eaac1a952f4468d8ea888d9339d0c0f/b13903b3015447ff8612a8b3d3c5873a.jpg, createdBy=0ef72434628, createdName=444265402_65524407, createdTime=Mon Feb 08 22:52:43 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082411, encodeId=550c10824117e, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:13 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973643, encodeId=47ff9e3643a6, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/7569b126444c4b1b9ab8cbd298657008/59c094a3153443d698ed34d3414795a2.jpg, createdBy=eb1f5428506, createdName=医海无涯苦作舟, createdTime=Tue Jun 15 08:26:51 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952452, encodeId=0ea895245260, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f45460280, createdName=ms4000001483995114, createdTime=Tue Mar 30 19:14:41 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923790, encodeId=1a75923e9040, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/7eaac1a952f4468d8ea888d9339d0c0f/b13903b3015447ff8612a8b3d3c5873a.jpg, createdBy=0ef72434628, createdName=444265402_65524407, createdTime=Mon Feb 08 22:52:43 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-06-15 医海无涯苦作舟

    学习了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082411, encodeId=550c10824117e, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:13 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973643, encodeId=47ff9e3643a6, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/7569b126444c4b1b9ab8cbd298657008/59c094a3153443d698ed34d3414795a2.jpg, createdBy=eb1f5428506, createdName=医海无涯苦作舟, createdTime=Tue Jun 15 08:26:51 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952452, encodeId=0ea895245260, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f45460280, createdName=ms4000001483995114, createdTime=Tue Mar 30 19:14:41 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923790, encodeId=1a75923e9040, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/7eaac1a952f4468d8ea888d9339d0c0f/b13903b3015447ff8612a8b3d3c5873a.jpg, createdBy=0ef72434628, createdName=444265402_65524407, createdTime=Mon Feb 08 22:52:43 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-03-30 ms4000001483995114

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082411, encodeId=550c10824117e, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:13 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973643, encodeId=47ff9e3643a6, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/7569b126444c4b1b9ab8cbd298657008/59c094a3153443d698ed34d3414795a2.jpg, createdBy=eb1f5428506, createdName=医海无涯苦作舟, createdTime=Tue Jun 15 08:26:51 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952452, encodeId=0ea895245260, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78f45460280, createdName=ms4000001483995114, createdTime=Tue Mar 30 19:14:41 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923790, encodeId=1a75923e9040, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/7eaac1a952f4468d8ea888d9339d0c0f/b13903b3015447ff8612a8b3d3c5873a.jpg, createdBy=0ef72434628, createdName=444265402_65524407, createdTime=Mon Feb 08 22:52:43 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-02-08 444265402_65524407

    👍

    0